Léonello Cusan
- Formation
- à venir
Aucune offre active
Autres opportunités de carrière
- Axe principal
- Endocrinologie et génomique
- Adresse
- 2705, boulevard Laurier, T-R-27
Québec (Québec)
CANADA G1V 4G2 - Téléphone
- +1 418-525-4444, poste 46018
- Télécopieur
- +1 418-654-2298
- Courriel
- Leonello.Cusan@crchul.ulaval.ca
Projet(s) de recherche reconnu(s) par l'Université Laval
Autre(s) projet(s) de recherche actif(s)
Aucun projet de recherche à afficher
Publications récentes (voir toutes les publications de ce chercheur)
Labrie F, Archer DF, Bouchard C, Fortier M, Cusan L, Gomez JL, Girard G, Baron M, Ayotte N, Moreau M, Dube R, Cote I, Labrie C, Lavoie L, Berger L, Gilbert L, Martel C, Balser J. Intravaginal dehydroepiandrosterone (prasterone), a highly efficient treatment of dyspareunia. Climacteric : the journal of the International Menopause Society,
2011. 14: 282-8
Labrie F, Archer D, Bouchard C, Fortier M, Cusan L, Gomez JL, Girard G, Baron M, Ayotte N, Moreau M, Dube R, Cote I, Labrie C, Lavoie L, Berger L, Martel C, Balser J. High internal consistency and efficacy of intravaginal DHEA for vaginal atrophy. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology,
2010. 26: 524-32
Labrie F, Archer D, Bouchard C, Fortier M, Cusan L, Girard G, Baron M, Ayotte N, Moreau M, Dubé R, Côté I, Labrie C, Lavoie L, Martel C, Balser J. Effect of intravaginal DHEA in postmenopausal women with vaginal atrophy and pain at sexual activity (dyspareunia) as most bothersome symptom In: Ben-Rafael Z, ed. Proceedings of the 13th World Congress on Controversies in Obstetrics, Gynecology & Infertility (COGI), November 4-7, 2010, Berlin, Germany Berlin: Monduzzi Editore, 2010. p.234-238.
Labrie F, Cusan L, Gomez JL, Cote I, Berube R, Belanger P, Martel C, Labrie C. Effect of one-week treatment with vaginal estrogen preparations on serum estrogen levels in postmenopausal women. Menopause (New York, N.Y.)
,
2009. 16: 30-6
Levesque MH, El-Alfy M, Cusan L, Labrie F. Androgen receptor as a potential sign of prostate cancer metastasis. The Prostate,
2009. 69: 1704-11
Labrie F, Cusan L, Gomez JL, Martel C, Berube R, Belanger P, Belanger A, Vandenput L, Mellstrom D, Ohlsson C. Comparable amounts of sex steroids are made outside the gonads in men and women: strong lesson for hormone therapy of prostate and breast cancer. The Journal of steroid biochemistry and molecular biology,
2009. 113: 52-6
Labrie F, Archer D, Bouchard C, Fortier M, Cusan L, Gomez JL, Girard G, Baron M, Ayotte N, Moreau M, Dube R, Cote I, Labrie C, Lavoie L, Berger L, Gilbert L, Martel C, Balser J. Effect of intravaginal dehydroepiandrosterone (Prasterone) on libido and sexual dysfunction in postmenopausal women. Menopause (New York, N.Y.),
2009. 16: 923-31
Labrie F, Archer D, Bouchard C, Fortier M, Cusan L, Gomez JL, Girard G, Baron M, Ayotte N, Moreau M, Dube R, Cote I, Labrie C, Lavoie L, Berger L, Gilbert L, Martel C, Balser J. Intravaginal dehydroepiandrosterone (Prasterone), a physiological and highly efficient treatment of vaginal atrophy. Menopause (New York, N.Y.),
2009. 16: 907-22
Labrie F, Archer D, Bouchard C, Fortier M, Cusan L, Gomez JL, Girard G, Baron M, Ayotte N, Moreau M, Dube R, Cote I, Labrie C, Lavoie L, Berube R, Belanger P, Berger L, Gilbert L, Martel C, Balser J. Serum steroid levels during 12-week intravaginal dehydroepiandrosterone administration. Menopause (New York, N.Y.),
2009. 16: 897-906
Labrie F, Cusan L, Gomez JL, Cote I, Berube R, Belanger P, Martel C, Labrie C. Effect of intravaginal DHEA on serum DHEA and eleven of its metabolites in postmenopausal women. The Journal of steroid biochemistry and molecular biology,
2008. 111: 178-94
